General Information of Drug (ID: DM0XDFG)

Drug Name
S-(4-Bromobenzyl)isothiourea hydrobromide
Synonyms
111039-41-9; 4-bromobenzyl carbamimidothioate hydrobromide; S-(4-Bromobenzyl)isothiourea hydrobromide; {[(4-Bromophenyl)methyl]sulfanyl}methanimidamide hydrobromide; CHEMBL1224314; ([(4-Bromophenyl)methyl]sulfanyl)methanimidamide hydrobromide; SCHEMBL854064; KS-00001OGW; MolPort-002-945-994; STK099425; NSC403785; AKOS005396363; NSC-403785
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski):
0
Molecular Weight 326.05
Logarithm of the Partition Coefficient Not Available
Rotatable Bond Count 3
Hydrogen Bond Donor Count 3
Hydrogen Bond Acceptor Count 2
Chemical Identifiers
Formula
C8H10Br2N2S
IUPAC Name
(4-bromophenyl)methyl carbamimidothioate;hydrobromide
Canonical SMILES
C1=CC(=CC=C1CSC(=N)N)Br.Br
InChI
InChI=1S/C8H9BrN2S.BrH/c9-7-3-1-6(2-4-7)5-12-8(10)11;/h1-4H,5H2,(H3,10,11);1H
InChIKey
PHMCIGUUXGYEBU-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
12465608
TTD ID
D03JAE

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Indoleamine 2,3-dioxygenase 1 (IDO1) TTZJYKH I23O1_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase. Bioorg Med Chem Lett. 2010 Sep 1;20(17):5126-9.